Literature DB >> 14748827

Molecular analysis of myophosphorylase deficiency in Dutch patients with McArdle's disease.

M A Martín1, J C Rubio, R A Wevers, B G M Van Engelen, G C H Steenbergen, O P Van Diggelen, M De Visser, C De Die-Smulders, A Blázquez, A L Andreu, J Arenas.   

Abstract

We report on 8 Dutch patients with McArdle's disease from 6 unrelated families. Molecular analysis revealed the presence of four previously described mutations: the common R49X mutation, the IVS14+1G>A mutation and the recently reported R269X and Y84X nonsense mutations; and two new molecular defects: a missense mutation R138W in the homozygous state in two siblings, and a frameshift mutation c.1797delT. This first genetic study of patients from The Netherlands with McArdle's disease confirms that the R49X mutation is also the most common in Dutch patients, and that there is genetic heterogeneity within this population. Moreover, our data support the hypothesis that the Y84X mutation is a relatively frequent mutation in McArdle's patients with a Central European background, and expand the already crowded map of mutations within the PYGM gene responsible for McArdle's disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14748827     DOI: 10.1046/j.1529-8817.2003.00067.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  8 in total

Review 1.  Molecular genetics of McArdle's disease.

Authors:  G Nogales-Gadea; J Arenas; A L Andreu
Journal:  Curr Neurol Neurosci Rep       Date:  2007-01       Impact factor: 5.081

2.  The pathogenomics of McArdle disease--genes, enzymes, models, and therapeutic implications.

Authors:  Gisela Nogales-Gadea; Alfredo Santalla; Astrid Brull; Noemi de Luna; Alejandro Lucia; Tomàs Pinós
Journal:  J Inherit Metab Dis       Date:  2014-07-23       Impact factor: 4.982

3.  Analysis of spectrum and frequencies of mutations in McArdle disease. Identification of 13 novel mutations.

Authors:  M Deschauer; A Morgenroth; P R Joshi; D Gläser; P F Chinnery; J Aasly; H Schreiber; M Knape; S Zierz; M Vorgerd
Journal:  J Neurol       Date:  2007-04-03       Impact factor: 4.849

Review 4.  McArdle disease: molecular genetic update.

Authors:  A L Andreu; G Nogales-Gadea; D Cassandrini; J Arenas; C Bruno
Journal:  Acta Myol       Date:  2007-07

5.  Myophosphorylase (PYGM) mutations determined by next generation sequencing in a cohort from Turkey with McArdle disease.

Authors:  Güldal Inal-Gültekin; Bahar Toptaş-Hekimoğlu; Zeliha Görmez; Özlem Gelişin; Hacer Durmuş; Bekir Ergüner; Hüseyin Demirci; Mahmut Ş Sağıroğlu; Yeşim Parman; Feza Deymeer; Hülya Yılmaz-Aydoğan; Sadrettin Pençe; Can Ebru Bekircan-Kurt; Ersin Tan; Sevim Erdem-Özdamar; Duran Üstek; Urs Giger; Oğuz Öztürk; Piraye Serdaroğlu-Oflazer
Journal:  Neuromuscul Disord       Date:  2017-06-16       Impact factor: 4.296

6.  Absence of p.R50X Pygm read-through in McArdle disease cellular models.

Authors:  Guillermo Tarrasó; Alberto Real-Martinez; Marta Parés; Lídia Romero-Cortadellas; Laura Puigros; Laura Moya; Noemí de Luna; Astrid Brull; Miguel Angel Martín; Joaquin Arenas; Alejandro Lucia; Antoni L Andreu; Jordi Barquinero; John Vissing; Thomas O Krag; Tomàs Pinós
Journal:  Dis Model Mech       Date:  2020-01-13       Impact factor: 5.758

7.  McArdle Disease and Exercise Physiology.

Authors:  Yu Kitaoka
Journal:  Biology (Basel)       Date:  2014-02-25

Review 8.  Preclinical Research in McArdle Disease: A Review of Research Models and Therapeutic Strategies.

Authors:  Mónica Villarreal-Salazar; Astrid Brull; Gisela Nogales-Gadea; Antoni L Andreu; Miguel A Martín; Joaquín Arenas; Alfredo Santalla; Alejandro Lucia; John Vissing; Thomas O Krag; Tomàs Pinós
Journal:  Genes (Basel)       Date:  2021-12-28       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.